Test Your Knowledge of eNSCLC Research Presented at ESMO!
Do you remember the eNSCLC research presented at ESMO? Test your knowledge now!
Read MoreDec 6, 2023
Do you remember the eNSCLC research presented at ESMO? Test your knowledge now!
Read MoreDec 5, 2023
The following is a summary of “Benefit of Allogeneic Transplant in 1st Complete Remission in...
Read MoreDec 5, 2023
The following is a summary of “Autologous Transplant (auto-HCT) Is Associated with Improved...
Read MoreDec 5, 2023
The following is a summary of “Addition of Acalabrutinib to Lenalidomide and Rituximab...
Read MoreDec 4, 2023
April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.
Read MoreDec 4, 2023
With over 275 exhibitors, the 65th ASH Annual Meeting exhibit hall is not to be missed!
Read MoreDec 4, 2023
Sign up today for the virtual 2023 ASH Foundation Run/Walk!
Read MoreDec 4, 2023
Make the most of your attendance at the 65th ASH annual meeting by utilizing these helpful resources to plan your schedule and stay informed!
Read MoreDec 4, 2023
The following is a summary of “Real-World Effectiveness and Safety Outcomes of Acalabrutinib...
Read MoreDec 3, 2023
At 2023 NACLC, Xiaohan Hu presented “Real-World Patients Characteristics, Biomarker Testing & Adjuvant Therapy for Resected NSCLC at US Oncology Clinics, 2019-2023”
Read MoreDec 3, 2023
At the 2023 NACLC, Benjamin Lok, MD, FRCPC, presented a radiation “mini-debate” focused on the “Goldie Locks Effect.”
Read MoreDec 3, 2023
At the 2023 NACLC, Florian Fintelman, MD, presented a recap of data on the use of artificial intelligence for lung cancer risk prediction on chest CT.
Read MoreDec 1, 2023
Forget the O’Hare food kiosks and grab lunch at one of these locations instead, all within easy walking distance from the Chicago Marriott Downtown Magnificent Mile
Read MoreDec 1, 2023
Don’t miss the 2023 NACLC closing keynote—Perioperative Therapy—to be given by Jonathan Spicer, MD, PhD, 11:15 a.m.-12:15 p.m., Sunday, December 3, 2023.
Read MoreDec 1, 2023
Make the most of your final day at the 2023 NACLC conference—use the program information below to plan your schedule:
Read MoreNov 27, 2023
Many barriers exist in the recruitment for diabetic macular edema clinical trials of patients of minority racial and ethnic backgrounds.
Read MoreNov 27, 2023
Key risk factors for progression independent of relapse activity in relapsing-remitting MS include age and longer disease duration.
Read MoreNov 27, 2023
More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.
Read MoreNov 22, 2023
2023 NACLC is taking place in Chicago’s famous “Magnificent Mile” district, so be sure to set aside a little time for exploring!
Read MoreNov 22, 2023
Check out the fascinating array of topics to be covered during 2023 NACLC satellite CME symposia!
Read More